Redefining multiple sclerosis: 2024 McDonald diagnostic criteria

Hazal Ceren Manazoğlu, Murat Kürtüncü

DOI: 10.55697/tnd.2025.500

Issue: 2025, Volume 31 - Issue 3
36037 15571

Association of lifestyle, psychological, and biological risk factors with multiple sclerosis: A case-control study

Rahim Aliyev, Aytan Mammadbayli, Rana Shiraliyeva

DOI: 10.55697/tnd.2025.494

Issue: 2025, Volume 31 - Issue 3
2855 2419

Long-term cladribine experience in relapsing-remitting multiple sclerosis

Ömer Faruk Turan, Furkan Sarıdaş, Emine Rabia Koç

DOI: 10.55697/tnd.2025.293

Issue: 2025, Volume 31 - Issue 3
2234 2067

Association between urinary symptoms, quality of life, and pelvic floor function in females diagnosed with multiple sclerosis

Seda Kılıç, Ayşe Neriman Yılmaz, Murat Terzi

DOI: 10.55697/tnd.2025.323

Issue: 2025, Volume 31 - Issue 4
1553 1440

Relationship between education status and cerebrovascular disease awareness in patients with ischemic stroke

Gizem Gürsoy, Havva Tuğba Çelik

DOI: 10.55697/tnd.2025.431

Issue: 2025, Volume 31 - Issue 4
1545 1192

Audiovestibular findings according to the subtypes of multiple sclerosis

Fatmanur Uysal, Selim S. Erbek, Alper Köycü, Osman Halit Çam, Meliha Güleryüz

DOI: 10.55697/tnd.2025.442

Issue: 2025, Volume 31 - Issue 4
1447 1671

Development of restless legs syndrome severity prediction models for people with multiple sclerosis using machine learning

Ergi Kaya, Murat Emeç, Asiye Tuba Özdoğar, Ela Simay Zengin, Hilal Karakaş, Seda Daştan, Cavid Baba, Mehmet Hilal Özcanhan, Serkan Özakbaş

DOI: 10.55697/tnd.2025.511

Issue: 2025, Volume 31 - Issue 4
1792 1624

Efficacy and safety of intravenous thrombolytic therapy in acute ischemic stroke: Predictors of good prognosis and outcomes of the elderly population

Burak Gürel, Vedat Ali Yürekli

DOI: 10.55697/tnd.2026.578

Issue: 2026, Volume 32 - Issue 1
1212 1114

Clinical prediction model for early neurological deterioration in patients with mild nondisabling ischemic stroke within 4.5 hours of onset

Lin Lu, Hongying Ma

DOI: 10.55697/tnd.2026.575

Issue: 2026, Volume 32 - Issue 1
2125 1167

Nationwide prescription big data: An evaluation of injectable, oral, and monoclonal antibody disease-modifying therapies in multiple sclerosis

Esra Taşkıran, Bilgin Öztürk, Naim Ata, Şuayip Birinci

DOI: 10.55697/tnd.2026.622

Issue: 2026, Volume 32 - Issue 1
1408 949

Rescue mechanical thrombectomy for large vessel occlusion during endovascular treatment of aneurysmal subarachnoid hemorrhage: A case report

Martin Vasilev, Vladina Dimitrova-Kirilova, Nora Ivanova, Tihomir Drenski, Georgi Todorov, Chavdar Bachvarov, Mihael Tsalta-Mladenov

DOI: 10.55697/tnd.2026.568

Issue: 2026, Volume 32 - Issue 1
1209 984

Six-month prognosis of acute ischemic stroke in patients with cancer: A prospective study

Hasan Hüseyin Kozak, Murat Araz, Ayşenur İnce, Ahmet Buğrul

DOI: 10.55697/tnd.2026.627

Issue: 2026, Volume 32 - Issue 2
1652 708

Determinants of stroke recurrence in a nationwide multicenter cohort

Nazlı Gamze Bülbül, Bilge Piri Çınar, Refik Kunt, Burcu Yüksel, Halil Güllüoğlu, İdris Saylır, Sibel Çeliker Uslu, Eylem Özaydın Göksu, Baykal Yıldız, Didem Öz, Ahmet Onur Keskin, Osman Korucu, Çetin Kürşad Akpınar, Volkan Solmaz, Meliha Türksever, Fatma Zehra Altunç, Zeynep Elmas, Mustafa Ekici, Murat Mert Atmaca, Sibel Karşıdağ, Mehmet Fatih Özdağ

DOI: 10.55697/tnd.2026.613

Issue: 2026, Volume 32 - Issue 2
1935 854

Recorded diagnosis-based incidence and point prevalence of multiple sclerosis in Azerbaijan between 2013 and 2022: Estimates from a national referral center registry

Rahim Aliyev, Ayten Mammadbayli, Rana Shiraliyeva

DOI: 10.55697/tnd.2026.749

Issue: 2026, Volume 32 - Issue 3
664 326